JP2017522907A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522907A5 JP2017522907A5 JP2017524123A JP2017524123A JP2017522907A5 JP 2017522907 A5 JP2017522907 A5 JP 2017522907A5 JP 2017524123 A JP2017524123 A JP 2017524123A JP 2017524123 A JP2017524123 A JP 2017524123A JP 2017522907 A5 JP2017522907 A5 JP 2017522907A5
- Authority
- JP
- Japan
- Prior art keywords
- coronavirus
- seq
- replicase gene
- leu
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1413020.7 | 2014-07-23 | ||
| GBGB1413020.7A GB201413020D0 (en) | 2014-07-23 | 2014-07-23 | Coronavirus |
| PCT/GB2015/052124 WO2016012793A1 (en) | 2014-07-23 | 2015-07-23 | Coronavirus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522907A JP2017522907A (ja) | 2017-08-17 |
| JP2017522907A5 true JP2017522907A5 (enExample) | 2018-05-31 |
| JP6712268B2 JP6712268B2 (ja) | 2020-06-17 |
Family
ID=51494985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017524123A Active JP6712268B2 (ja) | 2014-07-23 | 2015-07-23 | コロナウイルス |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10130701B2 (enExample) |
| EP (2) | EP3172319B1 (enExample) |
| JP (1) | JP6712268B2 (enExample) |
| KR (1) | KR20170032441A (enExample) |
| CN (2) | CN106536723B (enExample) |
| AU (1) | AU2015293633B2 (enExample) |
| BR (1) | BR112017001310B1 (enExample) |
| CA (1) | CA2953677C (enExample) |
| DK (1) | DK3172319T3 (enExample) |
| ES (1) | ES2764275T3 (enExample) |
| GB (1) | GB201413020D0 (enExample) |
| HU (1) | HUE047953T2 (enExample) |
| IL (1) | IL249340A0 (enExample) |
| MX (1) | MX373792B (enExample) |
| PL (1) | PL3172319T3 (enExample) |
| PT (1) | PT3172319T (enExample) |
| WO (1) | WO2016012793A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3055247C (en) * | 2017-03-03 | 2024-02-27 | Loyola University Chicago | Coronaviruses, vaccines comprising the same, and methods for preventing disease |
| KR20210084596A (ko) * | 2018-10-31 | 2021-07-07 | 베링거잉겔하임베트메디카게엠베하 | 이종 스파이크 단백질을 갖는 h52 ibv 백신 |
| KR102119875B1 (ko) * | 2019-03-19 | 2020-06-05 | 한국화학연구원 | 한국형 중동호흡기증후군 코로나바이러스 감염성 변이 유전자 및 이의 용도 |
| MX2021013728A (es) | 2019-05-10 | 2021-12-10 | Boehringer Ingelheim Vetmedica Gmbh | Ibv atenuado con tropismo de cultivo celular y tisular extendido. |
| CN111254155A (zh) * | 2020-01-25 | 2020-06-09 | 王跃驹 | 一种植物作为宿主表达病毒疫苗的方法 |
| CA3170374A1 (en) | 2020-02-09 | 2021-08-12 | Nlc Pharma Ltd | Rapid detection test for sars-cov-2 |
| BR112022019207A2 (pt) * | 2020-03-23 | 2022-11-08 | Univ Loyola Chicago | Composições de vacina para coronavírus e métodos de uso das mesmas |
| WO2021203236A1 (zh) * | 2020-04-07 | 2021-10-14 | 四川骋誉生物制品有限公司 | 用于预防covid-19的蝙蝠源性冠状病毒疫苗 |
| EP4635972A2 (en) | 2020-07-20 | 2025-10-22 | Enanta Pharmaceuticals, Inc. | Functionalized peptides as antiviral agents |
| CN112029781B (zh) * | 2020-08-14 | 2023-01-03 | 中山大学 | 一种新型冠状病毒SARS-CoV-2的安全型复制子系统及其应用 |
| JP2024004496A (ja) * | 2020-10-14 | 2024-01-17 | 一般財団法人阪大微生物病研究会 | ノックアウトコロナウイルス |
| US11384090B2 (en) | 2020-11-23 | 2022-07-12 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11976084B2 (en) | 2020-11-23 | 2024-05-07 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11352363B1 (en) | 2020-11-23 | 2022-06-07 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| CN112592905B (zh) * | 2020-12-28 | 2023-07-28 | 广州达安基因股份有限公司 | 用于新型冠状病毒检测的dna聚合酶混合物 |
| CN114751964B (zh) * | 2020-12-29 | 2024-03-08 | 苏州方舟生物科技有限公司 | β属冠状病毒通用疫苗蛋白片段及其筛选方法和应用 |
| US11970502B2 (en) | 2021-05-04 | 2024-04-30 | Enanta Pharmaceuticals, Inc. | Macrocyclic antiviral agents |
| US11319325B1 (en) | 2021-05-11 | 2022-05-03 | Enanta Pharmaceuticals, Inc. | Macrocyclic spiropyrrolidine derived antiviral agents |
| US12398147B2 (en) | 2021-05-11 | 2025-08-26 | Enanta Pharmaceuticals, Inc. | Macrocyclic spiropyrrolidine derived antiviral agents |
| CN113308440B (zh) * | 2021-05-26 | 2023-04-28 | 武汉大学 | 一种n7-甲基转移酶缺陷型冠状病毒减毒疫苗株及其制备方法与应用 |
| US11325916B1 (en) | 2021-07-29 | 2022-05-10 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11339170B1 (en) | 2021-07-23 | 2022-05-24 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US12479854B2 (en) | 2021-07-29 | 2025-11-25 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US20240390431A1 (en) * | 2021-09-22 | 2024-11-28 | Biomedit, Llc | Methods of Inhibiting Diseases Caused by Respiratory Viruses |
| US11912714B2 (en) | 2021-11-12 | 2024-02-27 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US11919910B2 (en) | 2021-11-12 | 2024-03-05 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| WO2023086350A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Alkyne-containing antiviral agents |
| US12145941B2 (en) | 2021-12-08 | 2024-11-19 | Enanta Pharmaceuticals, Inc. | Heterocyclic antiviral agents |
| WO2023107419A1 (en) | 2021-12-08 | 2023-06-15 | Enanta Pharmaceuticals, Inc. | Saturated spirocyclics as antiviral agents |
| WO2023196307A1 (en) | 2022-04-05 | 2023-10-12 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| WO2024191944A2 (en) * | 2023-03-10 | 2024-09-19 | The Regents Of The University Of California | Broad-spectrum multi-antigen pan-coronavirus vaccine |
| WO2025055902A1 (en) * | 2023-09-11 | 2025-03-20 | Boehringer Ingelheim Vetmedica (China) Co., Ltd. | Attenuated infectious bronchitis virus and a vaccine comprising the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1610817T1 (sl) | 2003-03-03 | 2010-01-29 | Intervet Int Bv | Virus infekcijskega bronhitisa s spremenjenim spike genom |
| CA2522379C (en) | 2003-04-10 | 2012-10-23 | Chiron Corporation | The severe acute respiratory syndrome coronavirus |
| EP1533370A1 (en) * | 2003-11-18 | 2005-05-25 | ViroNovative B.V. | Novel atypical pneumonia-causing virus |
| CN100413537C (zh) * | 2004-01-29 | 2008-08-27 | 国家人类基因组南方研究中心 | Sars冠状病毒全病毒疫苗 |
| US7452542B2 (en) * | 2004-05-21 | 2008-11-18 | Vanderbilt University | Live attenuated coronavirus vaccines |
| WO2007078203A1 (en) | 2006-01-03 | 2007-07-12 | Norwex Holding As | Anti-bacterial micro-fibre and production thereof |
| GB0911794D0 (en) * | 2009-07-07 | 2009-08-19 | Animal Health Inst | Chimaeric protein |
| CN102851257A (zh) * | 2012-08-27 | 2013-01-02 | 上海启盛生物科技有限公司 | 一种鸡传染性支气管炎病毒减毒疫苗株及其应用 |
| CN103397002A (zh) * | 2013-08-07 | 2013-11-20 | 广东温氏食品集团股份有限公司 | 禽传染性支气管炎病毒的致弱方法 |
-
2014
- 2014-07-23 GB GBGB1413020.7A patent/GB201413020D0/en not_active Ceased
-
2015
- 2015-07-23 CN CN201580037402.1A patent/CN106536723B/zh active Active
- 2015-07-23 MX MX2016016722A patent/MX373792B/es active IP Right Grant
- 2015-07-23 EP EP15750093.5A patent/EP3172319B1/en active Active
- 2015-07-23 HU HUE15750093A patent/HUE047953T2/hu unknown
- 2015-07-23 CN CN202411677449.1A patent/CN120098946A/zh active Pending
- 2015-07-23 BR BR112017001310-0A patent/BR112017001310B1/pt active IP Right Grant
- 2015-07-23 JP JP2017524123A patent/JP6712268B2/ja active Active
- 2015-07-23 AU AU2015293633A patent/AU2015293633B2/en active Active
- 2015-07-23 CA CA2953677A patent/CA2953677C/en active Active
- 2015-07-23 PT PT157500935T patent/PT3172319T/pt unknown
- 2015-07-23 PL PL15750093T patent/PL3172319T3/pl unknown
- 2015-07-23 EP EP19208113.1A patent/EP3656856B1/en active Active
- 2015-07-23 KR KR1020177004614A patent/KR20170032441A/ko not_active Ceased
- 2015-07-23 WO PCT/GB2015/052124 patent/WO2016012793A1/en not_active Ceased
- 2015-07-23 US US15/328,179 patent/US10130701B2/en active Active
- 2015-07-23 DK DK15750093.5T patent/DK3172319T3/da active
- 2015-07-23 ES ES15750093T patent/ES2764275T3/es active Active
-
2016
- 2016-12-01 IL IL249340A patent/IL249340A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017522907A5 (enExample) | ||
| JP6712268B2 (ja) | コロナウイルス | |
| Bande et al. | Progress and challenges toward the development of vaccines against avian infectious bronchitis | |
| CN102574897B (zh) | 嵌合蛋白 | |
| JP2022551805A (ja) | 卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス | |
| EP2094299A1 (en) | Recombinant modified vaccinia virus ankara (mva)-based vaccine for the avian flu | |
| Abozeid | Global emergence of infectious bronchitis virus variants: evolution, immunity, and vaccination challenges | |
| JP2008522621A (ja) | 世界的に流行するトリインフルエンザに対して迅速に応答するためのワクチン | |
| RU2018130683A (ru) | Аттенуированный вирус инфекционного бронхита | |
| US20210205436A1 (en) | Recombinant mopeia virus and vaccine platform | |
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| US9969777B2 (en) | Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV) | |
| Guo et al. | The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development | |
| JP4691495B2 (ja) | コロナウイルススパイクｓ１融合蛋白及びその発現ベクター | |
| CN106520710A (zh) | 表达鸭坦布苏病毒prm和E蛋白重组新城疫病毒活载体疫苗的制备及应用 | |
| CA2962100C (en) | Virus-based expression vectors and uses thereof | |
| CN115697398A (zh) | 包含两种不同rna复制子颗粒的甲型猪流感病毒疫苗 | |
| TW202400800A (zh) | 用於預防和治療狂犬病毒感染的組合物和方法 | |
| CN115768785A (zh) | 包含含有编码病毒的不同神经氨酸酶抗原的第一、第二和第三核酸序列的核酸构建体的甲型猪流感病毒疫苗 | |
| CN115768472A (zh) | 包含具有特定基因顺序的核酸构建体的甲型猪流感病毒疫苗 | |
| RU2012117014A (ru) | Способ получения рекомбинантного капсидного белка вируса гепатита е. рекомбинантная вакцина для профилактики вирусного гепатита е. | |
| JP2004508814A (ja) | タンデム配置された２つの遺伝子をコードする２シストロンｖＲＮＡを担持する組換えインフルエンザウイルス | |
| JP2025513753A (ja) | ワントゥーストップ（ｏｎｅ－ｔｏ－ｓｔｏｐ）弱毒化ＳＡＲＳ－ＣｏＶ－２ウイルス | |
| JP2006121948A (ja) | 組換えウイルス | |
| CN116200349A (zh) | 一种基于改良痘苗病毒天坛株的新型冠状病毒疫苗 |